Search - tctmd.com

Displaying 1 - 20 of 957

Sort: Relevancy | Date

SCOUT-HCM: Mavacamten Can Benefit Teens With Obstructive HCM, Too

News Conference News ACC 2026

SCOUT-HCM: Mavacamten Can Benefit Teens With Obstructive HCM, Too

March 30, 2026

SPIRIT-HF: Spironolactone’s Benefit Still Uncertain in HF With Preserved, Mildly Reduced EF

News Conference News ACC 2026

SPIRIT-HF: Spironolactone’s Benefit Still Uncertain in HF With Preserved, Mildly Reduced EF

March 29, 2026

US Societies Lay Out Requirements for Transcatheter Tricuspid Valve Procedures

News Daily News

US Societies Lay Out Requirements for Transcatheter Tricuspid Valve Procedures

Michael O'Riordan

March 27, 2026

March 2026 Dispatch for the CV Team

News Opinion CV Team Dispatch

March 2026 Dispatch for the CV Team

March 26, 2026

What’s Going to Be Hot at ACC 2026

News Conference News ACC 2026

What’s Going to Be Hot at ACC 2026

Michael O'Riordan

March 20, 2026

Two Conduction-System Pacing RCTs Give Conflicting Results

News Daily News

Two Conduction-System Pacing RCTs Give Conflicting Results

March 20, 2026

Ultraprocessed Food Again Linked to Higher CVD Risk: MESA

News Daily News

Ultraprocessed Food Again Linked to Higher CVD Risk: MESA

Michael O'Riordan

March 17, 2026

AI for Heart Failure Care Is Evolving Rapidly, THT 2026 Makes Clear

News Conference News THT 2026

AI for Heart Failure Care Is Evolving Rapidly, THT 2026 Makes Clear

March 10, 2026

AI-Enabled Virtual HF Care May Help Boost GDMT, Stabilize Weight

News Conference News THT 2026

AI-Enabled Virtual HF Care May Help Boost GDMT, Stabilize Weight

March 03, 2026

TCTMD’s Top 10 Most Popular Stories for February 2026

News Opinion Editor's Corner

TCTMD’s Top 10 Most Popular Stories for February 2026

Michael O'Riordan

March 02, 2026

Q&A Lior Jankelson on AI Tools for Suspected ACS and More

News Daily News

Q&A: Lior Jankelson on AI Tools for Suspected ACS and More

February 10, 2026

Oral GLP-1s Provide Benefit in HF Patients: SOUL Subanalysis

News Daily News

Oral GLP-1s Provide Benefit in HF Patients: SOUL Subanalysis

February 06, 2026

Nearly 150 Million US Adults Eligible for CKM Syndrome Meds

News Daily News

Nearly 150 Million US Adults Eligible for CKM Syndrome Meds

February 02, 2026

Even With Optimized GDMT, HFrEF Prognosis Remains Dire

News Daily News

Even With Optimized GDMT, HFrEF Prognosis Remains Dire

Michael O'Riordan

January 30, 2026

Heart Disease Remains Number One Killer of Americans

News Daily News

Heart Disease Remains Number One Killer of Americans

January 22, 2026

HF Care Differs Among Asian Subgroups in the US

News Daily News

HF Care Differs Among Asian Subgroups in the US

January 16, 2026

JACC Debuts Data Digest on CV Health in the United States

News Daily News

JACC Debuts Data Digest on CV Health in the United States

January 12, 2026

TCTMD’s Biggest News of 2025

News Opinion Editor's Corner

TCTMD’s Biggest News of 2025

Michael O'Riordan

January 01, 2026

Year in Review: Tirzepatide, Finerenone, and Digitoxin Score Big in Heart Failure

News Daily News

Year in Review: Tirzepatide, Finerenone, and Digitoxin Score Big in Heart Failure

Michael O'Riordan

December 30, 2025

FDA Approves Aficamten for Obstructive HCM

News Daily News

FDA Approves Aficamten for Obstructive HCM

December 29, 2025

Country

First Name

Last Name

Email

Profession

Organization

Country

CAPTCHA

This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.